CPSA USA 2014

Defining the Challenges of the Modern Analytical Laboratory:
The Risks and Reality of Personalized Healthcare

Organizing Committee

Program Chairs
Paul Corcoran McKinley Scientific
Gary Valaskovic New Objective

Susan Abbatiello Thermo Fisher Scientific
Dave Abramowitz AB SCIEX
Bradley Ackermann Eli Lilly & Company
Mark Arnold Bristol-Myers Squibb
Kevin Bateman Merck
Chad Briscoe PRA Health Sciences
John Bulter Agilent Technologies
Hong Cai GlaxoSmithKline
Mark Cancilla Merck
Helene Cardasis Thermo Fisher Scientific
Donald Chace Pediatrix Analytical
Michelle Clasquin Agios
Lucinda Cohen Merck
Brad Coopersmith Waters Corporation
Paul Corcoran McKinley Scientific
Victor DeJesus CDC
Nicole Donnelly PharmaCadence Analytical Services
Emily Ehrenfeld Mozaic Solutions
Joe Fox AB Sciex
Tim Garrett University of Florida
Mark Hayward Active Ingredient Technologies
Gary Impey AB SCIEX
Qin Ji Bristol-Myers Squibb
Jonathan Josephs Thermo Fisher Scientific
Olga Kavetskaia AbbVie
Richard King PharmaCadence Analytical Services
Ronald Kong PTC Therapeutics
Ken Lewis OpAns
Min Liu Merck
Jasmine Lu Shimadzu
Carla Marshall-Waggett New Objective
Eric Milgram PepsiCo
Shane Needham Alturas Analytics
Tim Olah Bristol-Myers Squibb
Istvan Pelczer Princeton University
David Perlman Princeton University
Joanna Pols Merck
Noel Premkumar Alturas Analytics
Robyn Rourick Genentech
Nalini Sadagopan Agilent Technologies
Jim Shen Bristol-Myers Squibb
Petia Shipkova Bristol-Myers Squibb
Joe Siple Drummond Scientific
Martin Steel McKinley Scientific
Matt Szapacs GlaxoSmithKline
Gary Valaskovic New Objective
Roy Vaz Sanofi
Naidong Weng Janssen Pharmaceuticals
Tracie Williams CDC
Eric Yang GlaxoSmithKline
Nathan Yates University of Pittsburgh
Anthony Yeung Fox Chase Cancer Center
Ismael Zamora Molecular Discovery